Sakar Healthcare (India) Price Prediction
| SAKAR Stock | 294.10 5.85 2.03% |
Oversold Vs Overbought
49
Oversold | Overbought |
Quarterly Earnings Growth 1.571 | Quarterly Revenue Growth 0.255 |
Using Sakar Healthcare hype-based prediction, you can estimate the value of Sakar Healthcare Limited from the perspective of Sakar Healthcare response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Sakar Healthcare to buy its stock at a price that has no basis in reality. In that case, they are not buying Sakar because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Sakar Healthcare after-hype prediction price | INR 293.54 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Sakar |
Sakar Healthcare After-Hype Price Prediction Density Analysis
As far as predicting the price of Sakar Healthcare at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Sakar Healthcare or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Sakar Healthcare, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Sakar Healthcare Estimiated After-Hype Price Volatility
In the context of predicting Sakar Healthcare's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Sakar Healthcare's historical news coverage. Sakar Healthcare's after-hype downside and upside margins for the prediction period are 291.54 and 295.54, respectively. We have considered Sakar Healthcare's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Sakar Healthcare is very steady at this time. Analysis and calculation of next after-hype price of Sakar Healthcare is based on 3 months time horizon.
Sakar Healthcare Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Sakar Healthcare is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Sakar Healthcare backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Sakar Healthcare, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.05 | 2.00 | 0.56 | 0.10 | 1 Events / Month | 2 Events / Month | Very soon |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
294.10 | 293.54 | 0.19 |
|
Sakar Healthcare Hype Timeline
Sakar Healthcare is at this time traded for 294.10on National Stock Exchange of India of India. The entity has historical hype elasticity of -0.56, and average elasticity to hype of competition of -0.1. Sakar is forecasted to decline in value after the next headline, with the price expected to drop to 293.54. The average volatility of media hype impact on the company price is about 18.02%. The price decline on the next news is expected to be -0.19%, whereas the daily expected return is at this time at -0.05%. The volatility of related hype on Sakar Healthcare is about 101.94%, with the expected price after the next announcement by competition of 294.00. The book value of the company was at this time reported as 243.8. The company recorded earning per share (EPS) of 5.3. Sakar Healthcare had not issued any dividends in recent years. Assuming the 90 days trading horizon the next forecasted press release will be very soon. Check out Sakar Healthcare Basic Forecasting Models to cross-verify your projections.Sakar Healthcare Related Hype Analysis
Having access to credible news sources related to Sakar Healthcare's direct competition is more important than ever and may enhance your ability to predict Sakar Healthcare's future price movements. Getting to know how Sakar Healthcare's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Sakar Healthcare may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| KINGFA | Kingfa Science Technology | (3.75) | 1 per month | 0.00 | (0.13) | 3.60 | (3.65) | 9.31 | |
| RICOAUTO | Rico Auto Industries | 0.00 | 2 per month | 0.00 | (0.27) | 3.21 | (4.52) | 11.81 | |
| GATECHDVR | GACM Technologies Limited | (0.09) | 5 per month | 0.00 | (0.36) | 4.08 | (5.56) | 12.29 | |
| COSMOFIRST | COSMO FIRST LIMITED | (12.20) | 1 per month | 0.00 | (0.15) | 3.02 | (3.92) | 13.96 | |
| TBZ | Tribhovandas Bhimji Zaveri | (3.80) | 3 per month | 3.47 | 0.06 | 10.00 | (5.61) | 27.64 | |
| PARAGMILK | Parag Milk Foods | 13.63 | 4 per month | 2.53 | (0.02) | 5.30 | (4.75) | 12.83 | |
| HEUBACHIND | Heubach Colorants India | 1.10 | 2 per month | 3.20 | (0.01) | 6.95 | (3.00) | 28.86 | |
| CHEMCON | Chemcon Speciality Chemicals | (2.00) | 2 per month | 0.00 | (0.21) | 2.76 | (3.49) | 10.08 | |
| ARVIND | Arvind Limited | (16.80) | 2 per month | 0.00 | (0.06) | 3.58 | (3.29) | 23.01 | |
| LEMONTREE | Lemon Tree Hotels | 4.29 | 2 per month | 0.00 | (0.12) | 2.73 | (3.19) | 9.41 |
Sakar Healthcare Additional Predictive Modules
Most predictive techniques to examine Sakar price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Sakar using various technical indicators. When you analyze Sakar charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Sakar Healthcare Predictive Indicators
The successful prediction of Sakar Healthcare stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Sakar Healthcare Limited, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Sakar Healthcare based on analysis of Sakar Healthcare hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Sakar Healthcare's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Sakar Healthcare's related companies.
Story Coverage note for Sakar Healthcare
The number of cover stories for Sakar Healthcare depends on current market conditions and Sakar Healthcare's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Sakar Healthcare is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Sakar Healthcare's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
Sakar Healthcare Short Properties
Sakar Healthcare's future price predictability will typically decrease when Sakar Healthcare's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Sakar Healthcare Limited often depends not only on the future outlook of the potential Sakar Healthcare's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Sakar Healthcare's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 20.5 M | |
| Cash And Short Term Investments | 4.7 M |
Other Information on Investing in Sakar Stock
Sakar Healthcare financial ratios help investors to determine whether Sakar Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sakar with respect to the benefits of owning Sakar Healthcare security.